Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Opexa Therapeutics (OPXA)

Add to Watchlists
Create an Alert
1.63 -0.03  -1.51% NASDAQ Apr 23, 8:00PM BATS Real time Currency in USD
View Full Chart
OPXA Price Chart
View All Events

OPXA Events

Date Type Description
Feb 27 Misc Opexa Therapeutics, Inc. Q4 2013 Earnings Conference Call
Feb 27 Earnings Opexa Therapeutics, Inc. Q4 2013 Earnings Results.
Nov 08 Misc AGM Event for Opexa Therapeutics Inc
Nov 07 Misc Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Third Quarter 2013 Financial Results Conference Call
Nov 07 Earnings Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Third Quarter 2013 Financial Results.
Aug 14 Misc Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Second Quarter 2013 Financial Results
Aug 14 Earnings Second Quarter 2013 Financial Results.
May 14 Misc Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss First Quarter 2013 Financial Results
May 14 Earnings "Opexa Therapeutics First Quarter Earnings and Corporate Update".
View All Performance Charts

OPXA Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Opexa Therapeutics is down 12.10% over the last year vs S&P 500 Total Return up 22.59%, Progenics Pharmaceuticals down 22.40%, and Omeros up 203.3%.

Get Quote for
Advertisement

Portfolio Strategies Featuring OPXA

Did Opexa Therapeutics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

OPXA Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Texas
  • Incorporation Country: United States
  • Incorporation State/Province: Texas
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Biological Product (except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Opexa Therapeutics, Inc., Opexa Therapeutics, Inc., is engaged in developing personalized immunotherapy with the potential to treat illnesses, including multiple sclerosis. These therapies are based on the proprietary T-cell technology.

Recent Quotes

Symbol Price Chg Chg % Market Cap
OPXA 1.63 -0.03 -1.51% 45.04M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.